Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 11/20 | 0.50 |
| ▸ | BCHE | P06276 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13561372 | 0.85 | CHKA (0.49) | CHKABCHEACHEKDM4EALDH1A1 | |
| SCHEMBL9716874 | 0.81 | MEN1 (0.38) | CHKAKDM4EALDH1A1RAB9AMEN1 | |
| Hydrochloric Acid SCHEMBL29539277 | 0.78 | CHKA (0.49) | CHKABCHEACHEKDM4EALDH1A1 | |
| SCHEMBL14475780 | 0.77 | CHKA (0.41) | CHKABCHEACHEKDM4EALDH1A1 | |
| SCHEMBL19661291 | 0.77 | BCHE (0.56) | CHKABCHEACHEKDM4EALDH1A1 | |
| SCHEMBL13561376 | 0.75 | CHKA (0.53) | CHKABCHEACHEKDM4EALDH1A1 | |
| SCHEMBL28949028 | 0.72 | GSK3A (0.52) | CHKAKDM4EALDH1A1RAB9A | |
| SCHEMBL30008866 | 0.72 | GSK3A (0.52) | CHKAKDM4EALDH1A1RAB9A | |
| Benzyl Viologen SCHEMBL599497 | 0.71 | ALDH1A1 (0.75) | CHKAKDM4EALDH1A1RAB9AMEN1 | |
| SCHEMBL22422901 | 0.71 | ACHE (0.63) | CHKABCHEACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120276649-A1 | THIOL DETECTION | THE OREGON BOARD OF HIGHER EDUCATION ON BEHALF OF PORTLAND STATE UNIVERSITY | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120276649-A1 | THIOL DETECTION | GLO1, AHCY, BHMT2 | CHKA 2980/4885BCHE 242/4885ACHE 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.